Skip to Main Content

Author Details

Arman Jahangiri
Hamadan University of Medical Sciences
2010
54
29
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37274668Survival analysis of coagulation disorders: A retrospective study with a 5-year follow-up.Heliyon2023
37158391Symptomatic intracranial tumors in pregnancy: an updated management algorithm. Illustrative case.J Neurosurg Case Lessons2023
34003803Role of c-Met/β1 integrin complex in the metastatic cascade in breast cancer.JCI Insight2021
32041837Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.Cancer Res2020
32027343Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.JAMA Oncol2020
31470404From bench to bedside: trends in National Institutes of Health funding for neurosurgeons from 1991 to 2015.J Neurosurg2019
28598278Atypical pituitary adenoma: a clinicopathologic case series.J Neurosurg2018
30215558Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes.J Neurosurg2018
28475720Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.Neurosurgery2018
29462362Postoperative Delirium in Glioblastoma Patients: Risk Factors and Prognostic Implications.Neurosurgery2018
29681511A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.Cancer Cell2018
29303441A cross-sectional study of neurosurgical department chairs in the United States.J Neurosurg2018
27035164Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.J Neurosurg2017
28138554GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.JCI Insight2017
28379552In Reply: Factors Predicting Recurrence After Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities.Neurosurgery2017
28218903Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.Oncogene2017
28214592Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas.Mol Cell Endocrinol2017
28973887Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.Proc Natl Acad Sci U S A2017
28541497Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.Neurosurgery2017
27590786Patients cured of acromegaly do not experience improvement of their skull deformities.Pituitary2017
26976201Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.Lancet Oncol2016
26252454Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.J Neurosurg2016
26979924Frontal Sinus Morphometry in Relation to Surgically Relevant Landmarks in the United States Population.World Neurosurg2016
25200831Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.J Neurooncol2015
25683712HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth.Cell Rep2015
25746316Incidence of headache as a presenting complaint in over 1000 patients with sellar lesions and factors predicting postoperative improvement.Clin Neurol Neurosurg2015
25439754Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery.J Clin Neurosci2015
25594191Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.Neurosurgery2015
24146189Rathke's cleft cysts: review of natural history and surgical outcomes.J Neurooncol2014
25032545Rate and time course of improvement in endocrine function after more than 1000 pituitary operations.Neurosurgery2014
24834943Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.J Neurosurg2014
24657255Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: multimodality management, patient selection, and results.World Neurosurg2014
24308953Extended endoscopic endonasal approach for suprasellar Rathke's cleft cysts.J Clin Neurosci2014
24327727β1 integrin: Critical path to antiangiogenic therapy resistance and beyond.Cancer Res2014
23307858Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.Clin Cancer Res2013
24097859It takes two to tango: Dual inhibition of PI3K and MAPK in rhabdomyosarcoma.Clin Cancer Res2013
23889139Socioeconomic factors associated with pituitary apoplexy.J Neurosurg2013
23971964Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.J Neurosurg2013
23685641A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.Neurosurgery2013
23646141Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress.PLoS One2013
23644530β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.Cancer Res2013
23568697Endoscopic surgery for tuberculum sellae meningiomas: a systematic review and meta-analysis.Neurosurg Rev2013
23174359Skull base chordomas: clinical features, prognostic factors, and therapeutics.Neurosurg Clin N Am2013
23174355Minimally invasive approaches to the anterior skull base.Neurosurg Clin N Am2013
21740118Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss.J Neurosurg2012
22714142Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.Autophagy2012
22915758Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.Cancer Res2012
22447568Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.Cancer Res2012
22472177Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy.Clin Cancer Res2012
22440871Pseudoprogression and treatment effect.Neurosurg Clin N Am2012
  • 1 - 50 of 54

Recommended Authors

University of Toronto
Career Start Year 2013
Number of shared co-authors 4
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 0
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 11
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 1
Queen Mary Hospital
Career Start Year 2009
Number of shared co-authors 10
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 2
University of Florida
Career Start Year 2008
Number of shared co-authors 1
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 3
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 0
Leiden University Medical Center, Haaglanden Medical Center
Career Start Year 2006
Number of shared co-authors 4
Feinberg School of Medicine, Northwestern University
Career Start Year 2006
Number of shared co-authors 12
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 2
University of Toronto
Career Start Year 2003
Number of shared co-authors 50
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 2
Harvard Medical School
Career Start Year 2000
Number of shared co-authors 10
The University of Hong Kong
Career Start Year 1999
Number of shared co-authors 10
Weill Cornell Medical Center, NewYork Presbyterian Hospital
Career Start Year 1998
Number of shared co-authors 5
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 13
Gangnam Severance Hospital
Career Start Year 1995
Number of shared co-authors 0
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 9
University of Minnesota
Career Start Year 1994
Number of shared co-authors 5
The National Hospital of Denmark, Rigshospitalet
Career Start Year 1993
Number of shared co-authors 1
Rhode Island Hospital
Career Start Year 1992
Number of shared co-authors 2
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1990
Number of shared co-authors 7
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1981
Number of shared co-authors 2

Collaborators

University of California san francisco
Co-authored papers 48
Mayo Clinic
Co-authored papers 13
University of California San Francisco (UCSF)
Co-authored papers 10
University of California san francisco
Co-authored papers 9
University of California san francisco
Co-authored papers 8
Co-authored papers 7
University of California san francisco
Co-authored papers 6
University of Arkansas for Medical Sciences
Co-authored papers 6
University of California at San Francisco
Co-authored papers 6
Korea University
Co-authored papers 5
University of California san francisco
Co-authored papers 4
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers 4
University of California san francisco
Co-authored papers 4
California Pacific Medical Center Research Institute
Co-authored papers 3
3Montefiore Medical Center
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Co-authored papers 3
University of California san francisco
Co-authored papers 2
Co-authored papers 2
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Co-authored papers 2
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers 2
VIB-Center for Cancer Biology
Co-authored papers 2
University of California san francisco
Co-authored papers 1
Osaka University Graduate School of Medicine
Co-authored papers 1
University of Wollongong
Co-authored papers 1
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 1
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 1
Kitasato University School of Medicine
Co-authored papers 1
Erasmus MC Cancer Institute
Co-authored papers 1